Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5621916 | Thrombosis Research | 2017 | 10 Pages |
Abstract
Treatment of DVT with rivaroxaban might be associated with a lower risk for PTS development. A larger randomized trial would be needed for stronger evidence.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
L. Jeraj, M.K. Jezovnik, P. Poredos,